Morgan Stanley »

Y Mabs Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Y Mabs Therapeutics shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.3M 293k 4.51
2024-12-31 $2.5M 321k 7.83
2024-09-30 $3.3M 249k 13.15
2024-06-30 $2.5M 203k 12.08
2024-03-31 $3.1M 188k 16.26
2023-12-31 $1.7M 245k 6.82
2023-09-30 $588k 108k 5.45
2023-06-30 $887k 131k 6.79
2022-12-31 $1.4M 294k 4.88
2022-06-30 $5.5M 374k 14.63
2022-03-31 $6.4M 542k 11.88
2021-06-30 $3.1M 92k 33.92
2020-12-31 $6.5M 132k 49.51
2020-09-30 $2.9M 75k 38.38
2020-06-30 $3.5M 82k 43.23
2020-03-31 $138k 5.3k 26.23
2019-12-31 $7.7M 247k 31.25
2019-09-30 $3.4M 131k 26.00
2019-03-31 $37k 1.4k 26.49
2018-12-31 $223k 11k 20.35
2018-09-30 $3.0k 100 30.00

Top funds holding Y Mabs Therapeutics